{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:29:07Z","timestamp":1787905747770,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.xphs.2017.02.023","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T21:00:04Z","timestamp":1488315604000},"page":"1466-1474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["In\u00a0Vitro and Ex\u00a0Vivo Permeability Studies of Paclitaxel and Doxorubicin From Drug-Eluting Biodegradable Ureteral Stents"],"prefix":"10.1016","volume":"106","author":[{"given":"Alexandre A.","family":"Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui L.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estev\u00e3o","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xphs.2017.02.023_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.xphs.2017.02.023_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","article-title":"A\u00a0comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract","volume":"95","author":"Stewart","year":"2005","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib3","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/bju.12025","article-title":"Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985\u20132010","volume":"112","author":"Eylert","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.xphs.2017.02.023_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<335::AID-SSU7>3.0.CO;2-E","article-title":"Treatment of superficial bladder cancer with intravesical chemotherapy","volume":"13","author":"Badalament","year":"1997","journal-title":"Semin Surg Oncol"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1040-8428(03)00075-1","article-title":"Intravesical therapy of superficial bladder cancer","volume":"47","author":"Malmstr\u00f6m","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.xphs.2017.02.023_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1464-410X.2008.07571.x","article-title":"Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer","volume":"101","author":"Hadaschik","year":"2008","journal-title":"BJU Int"},{"issue":"0","key":"10.1016\/j.xphs.2017.02.023_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2015.03.006","article-title":"Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy","volume":"72","author":"Lu","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2017.02.023_bib8","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1007\/s13277-014-2190-8","article-title":"Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes","volume":"36","author":"Papadopoulos","year":"2015","journal-title":"Tumor Biol"},{"issue":"4","key":"10.1016\/j.xphs.2017.02.023_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ucl.2006.06.012","article-title":"Local drug delivery to bladder using technology innovations","volume":"33","author":"Tyagi","year":"2006","journal-title":"Urol Clin North America"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2017.02.023_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/mp400274z","article-title":"An ex\u00a0vivo investigation into the transurothelial permeability and bladder wall distribution of the nonsteroidal anti-inflammatory Ketorolac","volume":"11","author":"Williams","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2017.02.023_bib12","series-title":"Operating Department Practice A-z","author":"Williams","year":"2008"},{"issue":"3","key":"10.1016\/j.xphs.2017.02.023_bib13","first-page":"763","article-title":"Evidence of nonuniformity in urothelium barrier function between the upper urinary tract and bladder","volume":"195","author":"Williams","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.xphs.2017.02.023_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2016.08.061","article-title":"Drug-eluting biodegradable ureteral stent: new approach for urothelial tumors of upper urinary tract cancer","volume":"513","author":"Barros","year":"2016","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2017.02.023_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jbm.b.33237","article-title":"Bioresorbable ureteral stents from natural origin polymers","volume":"103","author":"Barros","year":"2015","journal-title":"J\u00a0Biomed Mater Res B"},{"key":"10.1016\/j.xphs.2017.02.023_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmt.2016.07.006","article-title":"Gelatin-based biodegradable ureteral stents with enhanced mechanical properties","volume":"5","author":"Barros","year":"2016","journal-title":"Appl Mater Today"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ijpharm.2015.08.040","article-title":"Ketoprofen-eluting biodegradable ureteral stents by CO2 impregnation: in\u00a0vitro study","volume":"495","author":"Barros","year":"2015","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2017.02.023_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0090-4295(77)90211-4","article-title":"Ileal substitute of ureter with reflux-plasty by terminal intussusception of bowel animal experiments and clinical experience","volume":"9","author":"Tscholl","year":"1977","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib19","first-page":"265","article-title":"Histology and fine structure of the muscularis mucosae of the human urinary bladder","volume":"136","author":"Dixon","year":"1983","journal-title":"J\u00a0Anat"},{"issue":"9","key":"10.1016\/j.xphs.2017.02.023_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.05.011","article-title":"Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly","volume":"63","author":"de Villiers","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ten.teb.2010.0548","article-title":"Polyelectrolyte multilayers in tissue engineering","volume":"17","author":"Detzel","year":"2011","journal-title":"Tissue Eng B Rev"},{"issue":"24","key":"10.1016\/j.xphs.2017.02.023_bib22","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/adma.200600113","article-title":"Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering","volume":"18","author":"Tang","year":"2006","journal-title":"Adv Mater"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2017.02.023_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.memsci.2005.06.065","article-title":"Permeability of bacterial cellulose membranes","volume":"272","author":"Sokolnicki","year":"2006","journal-title":"J\u00a0Membr Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.02.023_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejps.2005.02.003","article-title":"Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium","volume":"25","author":"Kerec","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00280-010-1499-2","article-title":"The uptake of paclitaxel and docetaxel into ex\u00a0vivo porcine bladder tissue from polymeric micelle formulations","volume":"68","author":"Tsallas","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2017.02.023_bib26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/bm400314s","article-title":"Free-standing polyelectrolyte membranes made of chitosan and alginate","volume":"14","author":"Caridade","year":"2013","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.xphs.2017.02.023_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.memsci.2006.10.002","article-title":"Morphology and permeability of cellulose\/chitin blend membranes","volume":"287","author":"Liang","year":"2007","journal-title":"J\u00a0Membr Sci"},{"issue":"3","key":"10.1016\/j.xphs.2017.02.023_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2003.12.004","article-title":"Design of a novel hydrogel-based intelligent system for controlled drug release","volume":"95","author":"He","year":"2004","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2017.02.023_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1383-5866(99)00006-4","article-title":"Permeability of ionic solutes in a polyamphoteric membrane","volume":"16","author":"Matsuyama","year":"1999","journal-title":"Sep Purif Technol"},{"issue":"3","key":"10.1016\/j.xphs.2017.02.023_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2017.02.023_bib31","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1039\/c4py00207e","article-title":"An assessment of nanosponges for intravenous and oral drug delivery of BCS class IV drugs: drug delivery kinetics and solubilization","volume":"5","author":"Stevens","year":"2014","journal-title":"Polym Chem"},{"issue":"1","key":"10.1016\/j.xphs.2017.02.023_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14227\/DT180111P31","article-title":"Biopharmaceutics classification system: a regulatory approach","volume":"18","author":"Reddy","year":"2011","journal-title":"Dissol Technol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:21:50Z","timestamp":1758360110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0022354917301326"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.02.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0Vitro and Ex\u00a0Vivo Permeability Studies of Paclitaxel and Doxorubicin From Drug-Eluting Biodegradable Ureteral Stents","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}